|1.||Goulmy, Els: 10 articles (01/2013 - 01/2002)|
|2.||Dolstra, Harry: 6 articles (06/2014 - 11/2008)|
|3.||Falkenburg, J H Frederik: 6 articles (08/2012 - 04/2002)|
|4.||Korngold, Robert: 5 articles (09/2015 - 12/2003)|
|5.||Pool, Jos: 5 articles (01/2013 - 01/2002)|
|6.||Mullen, Craig A: 5 articles (02/2011 - 01/2002)|
|7.||Mutis, Tuna: 5 articles (11/2010 - 01/2002)|
|8.||Goulmy, E: 4 articles (07/2010 - 01/2000)|
|9.||Friedman, Thea M: 4 articles (03/2007 - 12/2003)|
|10.||Murphy, George F: 4 articles (03/2007 - 12/2003)|
07/07/1997 - "This is known to be effective for class I-restricted cytotoxic T lymphocyte (CTL) cross-priming directed against a variety of exogenous tumor, viral, and minor transplantation antigens. "
05/01/2010 - "Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors."
01/01/1986 - "Studies on histocompatibility antigens expression on different selected mouse tumor cells revealed very variable pattern. "
06/01/1977 - "Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse."
01/01/1966 - "Studies on the occurrence of common specific transplantation antigens in Rous tumors of various mammalian species."
|2.||Graft vs Host Disease (Graft-Versus-Host Disease)
09/01/2015 - "Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model."
03/15/2005 - "Mismatch for the adhesion molecule CD31 (PECAM-1) has been associated in some studies with graft-versus-host disease (GVHD), suggesting a role for CD31 as a minor histocompatibility antigen. "
07/15/2000 - "To study the role of the Fas/FasL pathway in the complex pathophysiology of graft versus host disease (GVHD), we used FasL-deficient B6.gld mice as recipients in a Major Histocompatibility Antigen Complex-matched minor Histocompatibility Antigen-mismatched murine model for GVHD after allogeneic BMT (C3H.SW-->B6). "
01/01/2013 - "Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone."
01/01/2012 - "Acute graft-versus-host disease (aGVHD), an allogeneic reaction triggered in response to minor and major histocompatibility antigen disparities between donor and recipient, remains the main source of morbidity and mortality in T-cell-replete allogeneic HSCT. "
02/01/2013 - "Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability."
10/01/2000 - "Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran."
08/01/1998 - "[Histocompatibility antigens in multiple sclerosis in children]."
07/01/1998 - "The class II major histocompatibility antigen DR15 is associated with multiple sclerosis in all groups except Sardinians, where the primary association is with DR4. "
01/01/1998 - "[Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis]."
|4.||Neoplasm Metastasis (Metastasis)
03/01/1989 - "Phenotypic expression of histocompatibility antigens in human primary tumours and metastases."
11/01/1986 - "Allogeneic LAK cells had little, if any, therapeutic effect on established pulmonary and hepatic metastases when administered to recipients previously immunized to the histocompatibility antigens on the donor cells. "
12/01/1986 - "Variants of neoplasms MCA-F, MCA-D, and MCA-2A were selected for proclivity for spontaneous lung metastasis and expression of parental tumor-specific transplantation antigens. "
11/15/1985 - "The anomalous expression of histocompatibility antigens in many neoplasms appears to be associated with the ability of these cells to evade the immune system and progress to metastasis. "
10/01/1980 - "Preventive effect of Propionibacterium acnes on metastasis in mice rendered tolerant to tumor-associated transplantation antigens."
|5.||Autoimmune Diseases (Autoimmune Disease)
05/01/1986 - "All eight patients with HAE who developed an autoimmune disease with a known human histocompatibility antigen association developed a disease associated with their histocompatibility antigen haplotype (p = 0.014). "
08/01/1985 - "[Histocompatibility antigens and autoimmune diseases]."
05/01/1984 - "Several autoimmune diseases have been associated with increased frequencies of various histocompatibility antigen (HLA) types that may be linked to immune response genes. "
12/01/1983 - "The histocompatibility antigens B8 and DR3 are associated with several autoimmune diseases, and immune hyper-responsiveness has been believed to be one factor in the pathogenesis of these diseases. "
05/01/1977 - "Autoimmune disease and histocompatibility antigen."
|2.||tumor-associated transplantation antigen (TSTA)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|6.||Transforming Growth Factor beta1 (TGF beta 1)
|7.||Interleukin-7 Receptor alpha Subunit
|8.||Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)
|9.||CCR5 Receptors (CCR5 Receptor)
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|4.||Transplantation (Transplant Recipients)
|5.||Homologous Transplantation (Allograft)